These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 39063049)

  • 1. In Vitro and In Vivo Human Metabolism of Ostarine, a Selective Androgen Receptor Modulator and Doping Agent.
    Taoussi O; Bambagiotti G; Gameli PS; Daziani G; Tavoletta F; Tini A; Basile G; Lo Faro AF; Carlier J
    Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39063049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of S22 (ostarine) in human nails and hair using LC-HRMS. Application to two authentic cases.
    Kintz P; Gheddar L; Ameline A; Raul JS
    Drug Test Anal; 2020 Oct; 12(10):1508-1513. PubMed ID: 32688441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elimination profiles of microdosed ostarine mimicking contaminated products ingestion.
    Walpurgis K; Rubio A; Wagener F; Krug O; Knoop A; Görgens C; Guddat S; Thevis M
    Drug Test Anal; 2020 Nov; 12(11-12):1570-1580. PubMed ID: 32959982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The forensic response after an adverse analytical finding (doping) involving a selective androgen receptor modulator (SARM) in human athlete.
    Kintz P
    J Pharm Biomed Anal; 2022 Jan; 207():114433. PubMed ID: 34715583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence of ostarine excretion in oral fluid after a single controlled oral administration.
    Kintz P; Gheddar L; Garnier D
    Clin Chim Acta; 2024 Apr; 557():117879. PubMed ID: 38499138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liquid chromatography-high resolution/ high accuracy (tandem) mass spectrometry-based identification of in vivo generated metabolites of the selective androgen receptor modulator ACP-105 for doping control purposes.
    Thevis M; Thomas A; Piper T; Krug O; Delahaut P; Schänzer W
    Eur J Mass Spectrom (Chichester); 2014; 20(1):73-83. PubMed ID: 24881457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro metabolism studies on the selective androgen receptor modulator (SARM) LG121071 and its implementation into human doping controls using liquid chromatography-mass spectrometry.
    Knoop A; Krug O; Vincenti M; Schänzer W; Thevis M
    Eur J Mass Spectrom (Chichester); 2015; 21(1):27-36. PubMed ID: 25906032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of anabolic agents including selective androgen receptor modulators in samples outside of sport.
    Bohlin KP; Pohanka A; Andersson A; Villén T; Ekström L
    Drug Test Anal; 2024 Aug; 16(8):827-834. PubMed ID: 37986708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of equine urinary metabolites of selective androgen receptor modulators (SARMs) S1, S4 and S22 for doping control purposes.
    Hansson A; Knych H; Stanley S; Thevis M; Bondesson U; Hedeland M
    Drug Test Anal; 2015 Aug; 7(8):673-83. PubMed ID: 25560998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Body fluid contamination in the context of an adverse analytical finding in doping: About a case involving ostarine.
    Alvarez JC; Etting I; Larabi IA
    Clin Chim Acta; 2024 Apr; 557():117871. PubMed ID: 38467244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultra high performance liquid chromatography tandem mass spectrometry determination and profiling of prohibited steroids in human biological matrices. A review.
    Gosetti F; Mazzucco E; Gennaro MC; Marengo E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May; 927():22-36. PubMed ID: 23317577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In silico and in vitro human metabolism of IOX2, a performance-enhancing doping agent.
    Taoussi O; Gameli PS; Berardinelli D; Busardò FP; Tini A; Carlier J
    J Pharm Biomed Anal; 2024 Jan; 238():115759. PubMed ID: 37866082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mass spectrometric characterization of urinary metabolites of the selective androgen receptor modulator S-22 to identify potential targets for routine doping controls.
    Thevis M; Thomas A; Möller I; Geyer H; Dalton JT; Schänzer W
    Rapid Commun Mass Spectrom; 2011 Aug; 25(15):2187-95. PubMed ID: 21710598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro metabolism study of a black market product containing SARM LGD-4033.
    Geldof L; Pozo OJ; Lootens L; Morthier W; Van Eenoo P; Deventer K
    Drug Test Anal; 2017 Feb; 9(2):168-178. PubMed ID: 26767942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of stanozolol O- and N-sulfate metabolites and their evaluation as additional markers in doping control.
    Balcells G; Matabosch X; Ventura R
    Drug Test Anal; 2017 Jul; 9(7):1001-1010. PubMed ID: 27714936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sulfate metabolites as alternative markers for the detection of 4-chlorometandienone misuse in doping control.
    Balcells G; Gómez C; Garrostas L; Pozo ÓJ; Ventura R
    Drug Test Anal; 2017 Jul; 9(7):983-993. PubMed ID: 27686240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of the selective androgen receptor modulator S-4 (Andarine) in a doping control sample.
    Starcevic B; Ahrens BD; Butch AW
    Drug Test Anal; 2013 May; 5(5):377-9. PubMed ID: 23427117
    [No Abstract]   [Full Text] [Related]  

  • 18. Characterization of a non-approved selective androgen receptor modulator drug candidate sold via the Internet and identification of in vitro generated phase-I metabolites for human sports drug testing.
    Thevis M; Lagojda A; Kuehne D; Thomas A; Dib J; Hansson A; Hedeland M; Bondesson U; Wigger T; Karst U; Schänzer W
    Rapid Commun Mass Spectrom; 2015 Jun; 29(11):991-9. PubMed ID: 26044265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of in vitro generated metabolites of LGD-4033, a selective androgen receptor modulator, in homogenized camel liver for anti-doping applications.
    Ondern Komathu P; Padusha MKSA; Laya S; Nalakath J; Palathinkal AB; Nelliyott I
    Rapid Commun Mass Spectrom; 2023 Nov; 37(22):e9633. PubMed ID: 37817338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural elucidation of major selective androgen receptor modulator (SARM) metabolites for doping control.
    Garg N; Hansson A; Knych HK; Stanley SD; Thevis M; Bondesson U; Hedeland M; Globisch D
    Org Biomol Chem; 2018 Jan; 16(5):698-702. PubMed ID: 29319101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.